天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

4H-Pyrido[1,2-a]pyrimidine-2-carboxylic acid, 4-oxo-

4H-Pyrido[1,2-a]pyrimidine-2-carboxylic acid, 4-oxo- Struktur
51081-64-2
CAS-Nr.
51081-64-2
Englisch Name:
4H-Pyrido[1,2-a]pyrimidine-2-carboxylic acid, 4-oxo-
Synonyma:
4-oxopyrido[1,2-a]pyrimidine-2-carboxylic acid;4-Oxo-4H-pyrido[1,2-a]pyrimidine-2-carboxylic acid;4H-Pyrido[1,2-a]pyrimidine-2-carboxylic acid, 4-oxo-
CBNumber:
CB78181403
Summenformel:
C9H6N2O3
Molgewicht:
190.16
MOL-Datei:
51081-64-2.mol

4H-Pyrido[1,2-a]pyrimidine-2-carboxylic acid, 4-oxo- Eigenschaften

Siedepunkt:
375.3±52.0 °C(Predicted)
Dichte
1.48±0.1 g/cm3(Predicted)
pka
-1.26±0.20(Predicted)

Sicherheit

4H-Pyrido[1,2-a]pyrimidine-2-carboxylic acid, 4-oxo- Chemische Eigenschaften,Einsatz,Produktion Methoden

4H-Pyrido[1,2-a]pyrimidine-2-carboxylic acid, 4-oxo- Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

4H-Pyrido[1,2-a]pyrimidine-2-carboxylic acid, 4-oxo- Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 7)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Nextpeptide Inc 		+86-0571-81612335 +8613336028439
 sales@nextpeptide.com China 19908 58
Hangzhou MolCore BioPharmatech Co.,Ltd. 		+86-057181025280; +8617767106207
 sales@molcore.com China 49734 58
Birdo (Shanghai) Medical Technology Co., Ltd. 021-58099077-8041 18601625411
 sales@birdotech.com China 9322 58
Taizhou Nanfeng Pharmaceutical Research Institute 18616377689
 nanfengdrug@163.com China 20000 58
Shanghai Haohong Pharmaceutical Co., Ltd. 4008210725 4008210725
 malulu@leyan.com China 54987 58
Hangzhou Taorui Biotechnology Co., Ltd 4000-360-990 15268198094
 sales@torreybio.com China 2885 58
Tianjin Jiayi Biotechnology Co., LTD 13261917876 13261917876
 503591062@qq.com China 338 58
  • 4H-Pyrido[1,2-a]pyrimidine-2-carboxylic acid, 4-oxo-
  • 4-Oxo-4H-pyrido[1,2-a]pyrimidine-2-carboxylic acid
  • 4-oxopyrido[1,2-a]pyrimidine-2-carboxylic acid
  • 51081-64-2
Copyright 2019 ? ChemicalBook. All rights reserved